John C. Reeder

John C. Reeder

Auto-generated profile, based on publicly available information

John C. Reeder

UNICEF/UNDP/WORLD BANK/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organisation (TDR), Geneva, 1211 Geneva 27, Switzerland

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2008 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
BGBlaise Genton
Blaise Genton
VDValérie D'ACremont
Valérie D'ACremont
LRLawrence Rare
Lawrence Rare
KBKay Baea
Kay Baea
JRJohn C Reeder
John C Reeder
IMIvo Müller
Ivo Müller
Severe malaria (SM) is classically associated with Plasmodium falciparum infection. Little information is available on the contribution of P. vivax to severe disease. There are some epidemiological indications that P. vivax or mixed infections protect against complications and deaths. A large morbidity surveillance conducted in an area where the four species coexist allowed us to estimate rates of SM among patients infected with one or several species. This was a prospective cohort study conducted within the framework of the Malaria Vaccine Epidemiology and Evaluation Project. All presumptive malaria cases presenting at two rural health facilities over an 8-y period were investigated with history taking, clinical examination, and laboratory assessment. Case definition of SM was based on the World Health Organization (WHO) criteria adapted for the setting (i.e., clinical diagnosis of malaria associated with asexual blood stage parasitaemia and recent history of fits, or coma, or respiratory distress, or anaemia [haemoglobin < 5 g/dl]). Out of 17,201 presumptive malaria cases, 9,537 (55%) had a confirmed Plasmodium parasitaemia. Among those, 6.2% (95% confidence interval [CI] 5.7%–6.8%) fulfilled the case definition of SM, most of them in children <5 y. In this age group, the proportion of SM was 11.7% (10.4%–13.2%) for P. falciparum, 8.8% (7.1%–10.7%) for P. vivax, and 17.3% (11.7%–24.2%) for mixed P. falciparum and P. vivax infections. P. vivax SM presented more often with respiratory distress than did P. falciparum (60% versus 41%, p = 0.002), but less often with anaemia (19% versus 41%, p = 0.0001). P. vivax monoinfections as well as mixed Plasmodium infections are associated with SM. There is no indication that mixed infections protected against SM. Interventions targeted toward P. falciparum only might be insufficient to eliminate the overall malaria burden, and especially severe disease, in areas where P. falciparum and P. vivax coexist.

1 April 1997 in Cell
Verified
Journal Article
Closed access
BCBrendan S. Crabb
Brendan S. Crabb
BCBrian M. Cooke
Brian M. Cooke
JRJohn C. Reeder
John C. Reeder
Ross WallerRoss Waller
Ross Waller
SCSonia R. Caruana
Sonia R. Caruana
ACAlan F. Cowman
Alan F. Cowman

24 May 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MJMuminatou Jallow
Muminatou Jallow
YTYik Ying Teo
Yik Ying Teo
KSKerrin S Small
Kerrin S Small
KRKirk A Rockett
Kirk A Rockett
PDPanos Deloukas
Panos Deloukas
AMAlphaxard Manjurano
Alphaxard Manjurano

9 December 2002 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AMAlexander G. Maier
Alexander G. Maier
MDManoj T. Duraisingh
Manoj T. Duraisingh
JRJohn C. Reeder
John C. Reeder
SPSheral S. Patel
Sheral S. Patel
JKJames W. Kazura
James W. Kazura
ACAlan F. Cowman
Alan F. Cowman

1 June 2007 in Trends in Parasitology
Verified
Journal Article
Closed access
IMIvo Mueller
Ivo Mueller
PZPeter A. Zimmerman
Peter A. Zimmerman
JRJohn C. Reeder
John C. Reeder

1 July 1995 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SRStephen J Rogerson
Stephen J Rogerson
SCS C Chaiyaroj
S C Chaiyaroj
KNK Ng
K Ng
JRJ C Reeder
J C Reeder
GBG V Brown
G V Brown
Adherence of Plasmodium falciparum-infected erythrocytes to cerebral postcapillary venular endothelium is believed to be a critical step in the development of cerebral malaria. Some of the possible receptors mediating adherence have been identified, but the process of adherence in vivo is poorly understood. We investigated the role of carbohydrate ligands in adherence, and we identified chondroitin sulfate (CS) as a specific receptor for P. falciparum-infected erythrocytes. Parasitized cells bound to Chinese hamster ovary (CHO) cells and C32 melanoma cells in a chondroitin sulfate-dependent manner, whereas glycosylation mutants lacking chondroitin sulfate A (CSA) supported little or no binding. Chondroitinase treatment of wild-type CHO cells reduced binding by up to 90%. Soluble CSA inhibited binding to CHO cells by 99.2 +/- 0.2% at 10 mg/ml and by 72.5 +/- 3.8% at 1 mg/ml, whereas a range of other glycosaminoglycans such as heparan sulfate had no effect. Parasite lines selected for increased binding to CHO cells and most patient isolates bound specifically to immobilized CSA. We conclude that P. falciparum can express or expose proteins at the surface of the infected erythrocyte that mediate specific binding to CSA. This mechanism of adherence may contribute to the pathogenesis of P. falciparum malaria, but has wider implications as an example of an infectious agent with the capacity to bind specifically to cell-associated or immobilized CS.